Suvoda, a clinical trial technology company, announced new split budget functionality within its Budgeting & Benchmarking solution, expanding how sponsors and CROs can manage complex site budget development across global studies and helping to accelerate the up-front work of clinical trials.

Budgeting & Benchmarking (formerly known as EnvisiX) is Suvoda's software for creating and structuring clinical trial site budgets using real-time, fair market value data. It helps sponsors and CROs create budgets with confidence while eliminating manual spreadsheets and email threads with a controlled, auditable workflow that connects budget creation more directly to downstream site payment execution.

In many regions, developing a clinical trial budget is more complex than a single agreement between a sponsor and a site. Multiple entities within a single site—such as investigators, radiology departments, laboratories, or affiliated institutions—often require separate contracts and payments. Historically, this has forced sponsors to manage portions of the process outside their budgeting tools, introducing inefficiencies, compliance risks, and delays.

Suvoda's new split budget capability enables sponsors to easily build and manage these multi-payee scenarios directly within the Budgeting & Benchmarking tool, supporting the range of global site operating models without leaving the system.

"Investigator grant budgeting is not just an administrative step in a clinical trial. It is foundational to the sponsor-site relationship and whether payments can be executed accurately and efficiently later," said Iain Wood, Senior Product Manager at Suvoda. "When budgeting processes require manual workarounds, it can impact clinical trial timelines, quality, and ultimately how quickly sites can begin enrolling patients."